Related content

Assessment of therapy response in malignant tumours with ¹⁸F-fluorothymidine

By Kumar Rakesh  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 9, 2007-09 ,pp. : 1334-1338

Springer Publishing Company

Access to resources Recommend Favorite

PET with [¹⁸F]fluorothymidine for imaging of primary breast cancer: a pilot study

By Smyczek-Gargya Brigitte   Fersis Nikos   Dittmann Helmut   Vogel Ulrich   Reischl Gerald   Machulla Hans-Juergen   Wallwiener Diethelm   Bares Roland   Dohmen Bernhard  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 5, 2004-05 ,pp. : 720-724

Springer Publishing Company

Access to resources Recommend Favorite

Is 3′-deoxy-3′-¹⁸F-fluorothymidine a better marker for tumour response than ¹⁸F-fluorodeoxyglucose?

By Reske Sven   Deisenhofer Sandra  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 1, 2006-07 ,pp. : 38-43

Springer Publishing Company

Access to resources Recommend Favorite

Initial evaluation of ¹⁸F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer

By Quon A.   Chang S.   Chin F.   Kamaya A.   Dick D.   Loo B.   Gambhir S.   Koong A.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 527-531

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT

By Nakajo Masatoyo   Nakajo Masayuki   Kajiya Yoriko   Jinguji Megumi   Nishimata Nobuaki   Shimaoka Shunji   Nihara Tohru   Aridome Kuniaki   Tanaka Sadao   Fukukura Yoshihiko   Tani Atushi   Koriyama Chihaya  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Iss. 8, 2013-08 ,pp. : 1223-1232

Springer Publishing Company

Access to resources Recommend Favorite